85 Five years of sequential LAM TO LAM+ADV therapy suppresses HBV replication in most HBeAg-negative cirrhotics, preventing decompensation but not hepatocellular carcinoma

Pietro Lampertico, Mauro Viganò, E. Manenti, Massimo Iavarone, G. Lunghi, M. Colombo

Journal of Hepatology · 2006 · 17 citations · 0 references

Concepts